A detailed history of Widmann Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Widmann Financial Services, Inc. holds 8,523 shares of ABBV stock, worth $1.53 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
8,523
Previous 8,579 0.65%
Holding current value
$1.53 Million
Previous $1.47 Million 14.41%
% of portfolio
1.28%
Previous 1.2%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $9,175 - $11,162
-56 Reduced 0.65%
8,523 $1.68 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $11,986 - $13,657
-75 Reduced 0.87%
8,579 $1.56 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $18,851 - $21,230
-137 Reduced 1.56%
8,654 $1.34 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $166,319 - $192,539
1,245 Added 16.5%
8,791 $1.31 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $25,176 - $31,331
-190 Reduced 2.46%
7,546 $1.02 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $289 - $333
2 Added 0.03%
7,736 $1.23 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $29,321 - $35,164
212 Added 2.82%
7,734 $1.25 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1,073 - $1,231
-8 Reduced 0.11%
7,522 $1.01 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $4,403 - $5,598
32 Added 0.43%
7,530 $1.15 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.03%
7,498 $1.22 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $805,295 - $1.02 Million
7,496 New
7,496 $1.02 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Widmann Financial Services, Inc. Portfolio

Follow Widmann Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Widmann Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Widmann Financial Services, Inc. with notifications on news.